Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Savareux

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Urology|April 25, 2006
Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?Laurent Guy, Laurent Savareux, Vincent Molinié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Spleno-gonadal fusion: differential diagnosis of a testicular tumor in an infant]Christophe Laplace, Laurent Savareux, Jean-Louis Stephan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 18, 2004
[Pyelo-ureteric amyloidosis]Laurent Savareux, Laurent Guy, Wassim Essamet, et al.
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Oncology|January 16, 2016
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II StudyHakim Mahammedi, Eloise Planchat, Mélanie Pouget, et al.
Cancer Medicine|March 5, 2021
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancerJudith Passildas-Jahanmohan, Jean-Christophe Eymard, Mélanie Pouget, et al.
World Journal of Urology|July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trialThierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Urology|April 25, 2006
Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?Laurent Guy, Laurent Savareux, Vincent Molinié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Spleno-gonadal fusion: differential diagnosis of a testicular tumor in an infant]Christophe Laplace, Laurent Savareux, Jean-Louis Stephan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 18, 2004
[Pyelo-ureteric amyloidosis]Laurent Savareux, Laurent Guy, Wassim Essamet, et al.
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
Oncology|January 16, 2016
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II StudyHakim Mahammedi, Eloise Planchat, Mélanie Pouget, et al.
Cancer Medicine|March 5, 2021
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancerJudith Passildas-Jahanmohan, Jean-Christophe Eymard, Mélanie Pouget, et al.
World Journal of Urology|July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trialThierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Pageof 1